{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:05:53Z","timestamp":1784549153940,"version":"3.55.0"},"reference-count":19,"publisher":"FapUNIFESP (SciELO)","issue":"6","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Assoc. Med. Bras."],"abstract":"<jats:p>SUMMARY  OBJECTIVE: In T4 colorectal cancer, the risk of peritoneal carcinomatosis is high, and the prognosis is poor. The aim of this study was to assess recurrence risk factors, peritoneal recurrence rates, and survival outcomes in patients radiologically diagnosed with T4 tumors who underwent curative surgery with prophylactic hyperthermic intraperitoneal chemotherapy.  METHODS: Between January 2018 and December 2022, 38 radiologically diagnosed T4 colorectal cancer patients who underwent prophylactic hyperthermic intraperitoneal chemotherapy were retrospectively analyzed. All patients had R0 resection; those with intraoperative macroscopic peritoneal or distant metastases were excluded. Demographic data, tumor location, histopathology, and pathological T\/N stages were recorded. During follow-up, local\/distant recurrence, peritoneal carcinomatosis, metastatic sites, and mortality were assessed.  RESULTS: The median age was 57 years, and 57.9% were male. The primary tumor originated mainly from the colon (81.6%), with moderately differentiated adenocarcinoma being the most common histology (57.8%). Recurrence occurred in four patients (10.5%): 2 hepatic, 1 pulmonary, and 1 peritoneal, with no local recurrence. One patient (2.6%) died within 90 days; no additional mortality was observed. Median overall survival was 55 months (95%CI 49.82\u201360.90). Univariate analysis showed no significant association between recurrence and tumor location, differentiation, pT or pN stage, or histologic subtype.  CONCLUSION: In cT4 colorectal cancer patients treated with prophylactic hyperthermic intraperitoneal chemotherapy, recurrence was infrequent, peritoneal recurrence was rare, and radiological staging frequently overestimated tumor depth, supporting a potential benefit of prophylactic hyperthermic intraperitoneal chemotherapy in this setting.<\/jats:p>","DOI":"10.1590\/1806-9282.20252167","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:23:13Z","timestamp":1784546593000},"source":"Crossref","is-referenced-by-count":0,"title":["Prophylactic hyperthermic \u0131ntraperitoneal chemotherapy for radiologic T4 colorectal cancer: impact on locoregional control"],"prefix":"10.1590","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6526-1821","authenticated-orcid":false,"given":"Vural","family":"Arg\u0131n","sequence":"first","affiliation":[{"name":"Marmara University,  T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5564-6923","authenticated-orcid":false,"given":"Ahmet Orhan","family":"Sunar","sequence":"additional","affiliation":[{"name":"University of Health Sciences,  T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8733-7279","authenticated-orcid":false,"given":"Nurdan","family":"Bezir","sequence":"additional","affiliation":[{"name":"University of Health Sciences,  T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9638-4031","authenticated-orcid":false,"given":"Muhammed Ikbal","family":"Ak\u0131n","sequence":"additional","affiliation":[{"name":"University of Health Sciences,  T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6527-9354","authenticated-orcid":false,"given":"\u00d6mer Faruk","family":"Kandaz","sequence":"additional","affiliation":[{"name":"University of Health Sciences,  T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0276-0543","authenticated-orcid":false,"given":"Mustafa","family":"Duman","sequence":"additional","affiliation":[{"name":"University of Health Sciences,  T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9463-9846","authenticated-orcid":false,"given":"Erdal","family":"Polat","sequence":"additional","affiliation":[{"name":"University of Health Sciences,  T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2026]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000543921","article-title":"Colorectal cancer: epidemiology, risk factors, and public health strategies","volume":"106","author":"Matsuda T","year":"2025","journal-title":"Digestion"},{"issue":"9","key":"ref2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/s41575-024-00934-z","article-title":"Mechanisms of metastatic colorectal cancer","volume":"21","author":"Ca\u00f1ellas-Socias A","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"33","key":"ref3","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.3748\/wjg.v30.i33.3818","article-title":"Early diagnostic strategies for colorectal cancer","volume":"30","author":"Liu SC","year":"2024","journal-title":"World J Gastroenterol"},{"key":"ref4","article-title":"What is the risk for peritoneal metastases and survival afterwards in T4 colon cancers?","author":"Uppal A","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/bjs.8679","article-title":"Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer","volume":"99","author":"Segelman J","year":"2012","journal-title":"Br J Surg"},{"issue":"7","key":"ref6","first-page":"804","article-title":"Value and controversy of prophylactic hyperthermic intraperitoneal chemotherapy in locally advanced colorectal cancer","volume":"28","author":"Lan B","year":"2025","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi"},{"issue":"7","key":"ref7","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamasurg.2023.0662","article-title":"Efficacy and safety of \u0131ntraoperative hyperthermic \u0131ntraperitoneal chemotherapy for locally advanced colon cancer: a phase 3 randomized clinical trial","volume":"158","author":"Arjona-S\u00e1nchez A","year":"2023","journal-title":"JAMA Surg"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1200\/JCO.22.02644","article-title":"Adjuvant hyperthermic \u0131ntraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): 5-year results of a randomized multicenter trial","volume":"42","author":"Zwanenburg ES","year":"2024","journal-title":"J Clin Oncol"},{"issue":"9","key":"ref9","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S1470-2045(20)30322-3","article-title":"Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study","volume":"21","author":"Go\u00e9r\u00e9 D","year":"2020","journal-title":"Lancet Oncol"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00423-021-02386-4","article-title":"Hepatic bridge and round ligament of the liver during cytoreductive surgery: a retrospective cohort","volume":"407","author":"Gulmez S","year":"2022","journal-title":"Langenbecks Arch Surg"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/jso.21059","article-title":"The Delphi approach to Attain consensus in methodology of local regional therapy for peritoneal surface malignancy","volume":"98","author":"Kusamura S","year":"2008","journal-title":"J Surg Oncol"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"17145","DOI":"10.1038\/s41598-024-68147-7","article-title":"Comparative evaluation of CT and MRI in the preoperative staging of colon cancer","volume":"14","author":"Bompou E","year":"2024","journal-title":"Sci Rep"},{"key":"ref13","series-title":"ACR appropriateness criteria\u00ae colorectal cancer screening","year":"2023"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3393\/ac.2017.33.6.255","article-title":"Accuracy of preoperative local staging of primary colorectal cancer by using computed tomography: reappraisal based on data collected at a highly organized cancer center","volume":"33","author":"So JS","year":"2017","journal-title":"Ann Coloproctol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"113314","DOI":"10.1016\/j.ejca.2023.113314","article-title":"Diagnostic accuracy of CT for local staging of colon cancer: a nationwide study in the Netherlands","volume":"193","author":"Shkurti J","year":"2023","journal-title":"Eur J Cancer"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.47717\/turkjsurg.2023.5706","article-title":"The evaluation of morbidity in gastrointestinal tumor patients underwent cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"39","author":"Aytin YE","year":"2023","journal-title":"Turk J Surg"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Qu\u00e9net F","year":"2021","journal-title":"Lancet Oncol"},{"issue":"1 Pt B","key":"ref18","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.amjsurg.2022.01.017","article-title":"Potential evidence of peritoneal recurrence in Stage-II colon cancer from the control arm of CALGB9581","volume":"224","author":"Dahdaleh FS","year":"2022","journal-title":"Am J Surg"},{"issue":"9","key":"ref19","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1016\/j.ejso.2021.05.009","article-title":"Risk of metachronous peritoneal metastases in patients with pT4a versus pT4b colon cancer: an international multicentre cohort study","volume":"47","author":"Bastiaenen VP","year":"2021","journal-title":"Eur J Surg Oncol"}],"container-title":["Revista da Associa\u00e7\u00e3o M\u00e9dica Brasileira"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0104-42302026000602204&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:23:15Z","timestamp":1784546595000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0104-42302026000602204&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":19,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026]]}},"alternative-id":["S0104-42302026000602204"],"URL":"https:\/\/doi.org\/10.1590\/1806-9282.20252167","relation":{},"ISSN":["1806-9282","0104-4230"],"issn-type":[{"value":"1806-9282","type":"electronic"},{"value":"0104-4230","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e20252167"}}